Intra-Cellular Therapies Inc (BSP:I2TC34)
R$ 84.24 0 (0%) Market Cap: 8.93 Bil Enterprise Value: 2.80 Bil PE Ratio: 0 PB Ratio: 7.86 GF Score: 31/100

Q3 2024 Intra-Cellular Therapies Inc Earnings Call Transcript

Oct 30, 2024 / 12:30PM GMT
Release Date Price: R$66.63
Operator

Good day, and thank you for standing by. Welcome to the Intra-Cellular Therapies 3Q 2024 Earnings Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded.

I would now like to hand the call over to Juan Sanchez, Head of Investor Relations. Please go ahead.

Juan Sanchez
Intra-Cellular Therapies Inc - Vice President - Corporate Communications and Investor Relations

Good morning, and thank you all for joining us on our third quarter 2024 earnings call. Joining me on the call today are Dr. Sharon Mates, Chairman and Chief Executive Officer; Mark Neumann, Chief Commercial Officer; Dr. Suresh Durgam, Chief Medical Officer; and Sanjeev Narula, Chief Financial Officer. A slide deck to complement today's call is available under the Investor Events section of our corporate website.

During today's call, we will be making certain forward-looking statements. These forward-looking statements are based on current information, assumptions and expectations. Those statements are subject to change and involve a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot